Research at University Health Network
 
Technology Transfer
Menu Level 3  
   
 
Norman N Iscove
Keywords: gene expression, microarrays, self-renewal, leukemia, hematopoietic stem cells, FACS purification 

Research Interests
Genetic Regulation of Self-Renewal and Differentiation in Normal and Leukemic Hematopoiesis

The production of blood cells and lymphocytes is maintained throughout life from multipotential hematopoietic stem cells in the bone marrow. When stem cells enter active growth, they generate two kinds of progeny. Some are pre-programmed to differentiate. Other progeny, generated in a process known as self-renewal, remain as stem cells, thereby guaranteeing the persistence of stem cells and the permanence of blood cell formation.

Competition between self-renewal and differentiation of stem cells is a feature common to the maintenance not only of most normal tissues but also of most cancers. Our work is concerned with the genes and mechanisms that specify self-renewal and differentiation in normal and leukemic hematopoietic stem cells.

We are interested in identifying known and novel genes that are specifically induced or downregulated in stem cells or subsequent early steps of differentiation. To do so, we need to be able to sample transcripts specifically from the various kinds of hematopoietic precursor cells.

Our lab has made advances in three areas that now place such stage-specific transcripts at our disposal. First, we have developed technology for amplifying all transcripts present in a single sampled cell while preserving relative abundance relationships. Next, by exploiting the similarity of differentiation potential of sibling cells within nascent clones, we have built up an extensive archive of amplified cDNA samples representative of key stages in hematopoietic precursor development. Finally, we have been able to purify the most primitive stem cells to near homogeneity, achieving in vivo reconstitution from each single cell injected into suitable murine hosts.

(Figure A and B below: 10 of 12 mice, each injected with an average of 1.4 purified stem cells, regenerate significant numbers of red cells of donor origin 8 weeks after transplant. The figure shows electrophoresis of peripheral erythrocyte proteins. In each lane, corresponding to one mouse, the upper band is donor erythrocyte GPI1a and the lower band is host GPI1b. For a band to be visible (1% of total GPI1) the transplanted cell must generate at least 200 million erythrocytes.)

We are using similar research strategies to unravel the genetic basis of maintenance of leukemic disease by leukemia stem cells. In human acute myeloblastic leukemia, leukemia cells in a patient differ widely from one another in potential for further growth. We have recently been able to demonstrate that proliferative potential is programmatically rather than randomly determined.

(Figure C below: Single leukemia cells were allowed to grow to form clones containing 4 cells each. Two such clones are illustrated schematically at the top of the figure. From each clone, single sister cells were transferred to individual culture wells and given time to multiply. Each sister cell from the clone at the left grew little or not at all, whereas all sister cells from the clone at the right grew extensively. The figure summarizes the general results obtained from hundreds of clones analyzed in this way: sibling leukemia cells share the same pre-programmed potential for growth.)

The observations have made it possible for the first time to sample cDNA specifically from leukemia cells possessing extensive versus modest versus extremely limited growth potential.

These advances are coupled with new technologies adapted and developed in the lab for retrieval of novel genes by subtractive hybridization, and for massively parallel detection of expression differences by hybridization of globally amplified cDNAs to gene microarrays.

(Figure D below: A portion of a glass slide imprinted with 1760 individual cDNA fragments. Globally amplified cDNA from 15 single growth- competent cells was labelled with Cy3 (green in illustration). Pooled cDNA from 18 single growth-incompetent cells was labelled with Cy5 (red). A mixture of the two labelled cDNA pools was hybridized to the chip. Green-labelled genes were expressed most strongly by growth-competent cells, red-coloured genes by growth-incompetent cells. Yellow/orange spots were labelled to similar extents by the two cDNAs.)

Subtractive work allowed us to identify and functionally characterize previously unknown genes expressed in more advanced precursor cells. We are now addressing differences in patterns of gene expression between normal multipotent cells with long-term reconstitution potential and more advanced multipotent cells that lack long-term growth potential.

We are also exploring expression differences between multipotent cells that have both myeloid and lymphoid potential, and multipotent cells that only have myeloid potential. Experiments with human leukemia cells similarly reveal significant differences in gene expression between samples differing in growth potential, and are directed at identifying key genes responsible for maintenance and extinction of proliferative potential in human leukemia.

Novel genes have been identified in each of these projects and are in early stages of investigation of their nature and function using bioinformatics, structural, overexpression and gene knockout technologies.

Pubmed Publications
Perform an automatic PubMed search of this researcher's publications.
 
 
Selected Publications

  • Resolution of pluripotential intermediates in murine hematopoietic differentiation by global cDNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcripts. F Billia, M Barbara, J McEwen, M Trevisan, NN Iscove. Blood 97:2257-2268, 2001.

  • Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterations. CM Morshead, P Benveniste, D van der Kooy and NN Iscove. Nature Medicine 8:268-73, 2002.

  • Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. NN Iscove, M Barbara, M Gu, M. Gibson, C. Modi, and N. Winegarden. Nature Biotechnology 20:940-943, 2002.

  • Hematopoietic stem cells engraft in mice with absolute efficiency. P Benveniste, C Cantin, D Hyam and NN Iscove. Nature Immunology 4:708-713, 2003.
 
Related Webpages
 
 
Laboratory and Research Photographs

Figure A and B 
Figure C and D 

  Norman  N Iscove
Mailing Address
Primary Office
MaRS Centre
Toronto Medical Discovery Tower
8th Floor Room 8-356
101 College St.
Toronto, Ontario
Canada M5G 1L7

 
Email
Phone Numbers
416-581-7460(Primary)
416-581-7461(LAB)

 
Staff and Trainees
Patricia Benveniste
Robert L Herrington
Deborah Hyam
Mary Barbara

   
 
 
 
Home Researchers Facilities Support Services Programs Commercialization Ethics News About UHN Institutes OCI Techna TGRI TRI TWRI